ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Home » Meeting Abstracts » ACR/ARHP Annual Meeting 2017

Abstract Number: 239

Ultrasound Abnormalities Predict Arthritis Development in ACPA and/or RF Positive Arthralgia Patients

Annelies Blanken1, Marian van Beers-Tas1, Marlies Meursinge Reynders1 and Dirkjan van Schaardenburg1,2, 1Amsterdam Rheumatology and immunology Center | Reade, Amsterdam, Netherlands, 2Amsterdam Rheumatology and immunology Center | Academic Medical Center, Amsterdam, Netherlands

Share on X (Twitter) Share on Facebook Share on LinkedIn Share on Email
Print

Meeting: ACR/ARHP Annual Meeting 2017

Date of first publication: September 18, 2017

Keywords: anti-CCP antibodies, Arthritis and ultrasound, Rheumatoid Factor

Session Information

Date: Sunday, November 5, 2017

Title: Imaging of Rheumatic Diseases Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:

Early diagnosis of rheumatoid arthritis (RA) is important for controlling disease activity and preventing joint damage. Individuals positive for anticitrullinated protein antibodies (ACPA) and/or rheumatoid factor (RF) are at risk of developing RA. In this study we investigated whether ultrasound (US) can predict development of arthritis in seropositive arthralgia patients.

Methods:

We included ACPA and/or RF positive patients with arthralgia, but without clinical arthritis. US was performed at baseline in 12 joints: bilateral MCP2-3, PIP2-3, wrist and MTP5. Images were scored semiquantitatively for synovitis and Power Doppler (PD) on a scale of 0-3. Grades 2 to 3 for synovitis and grades 1 to 3 for PD were regarded as abnormal. The association of ultrasound abnormalities with the development of arthritis was analyzed using Fisher’s exact test, expressed as odds ratios (OR) with 95% confidence interval (CI). Kaplan Meier survival analysis with log-rank test and Cox regression analysis were used to assess the timing of arthritis development, expressed as median time to arthritis and hazard ratios (HR) with 95% CI.

Results:

In total, 169 seropositive arthralgia patients underwent US examination. Mean age was 51 (standard deviation (SD) 11) and 73% was female. Of these patients, 44 (22%) developed arthritis during a mean follow-up time of 27 (SD 19) months. Thirty seven (84%) patients developing arthritis satisfied the 2010 ACR/EULAR classification criteria for RA. Synovitis and PD signal in at least one joint was observed in 14 (8%) and 7 (4%) patients, respectively. The presence of synovitis was associated with arthritis development  (OR  8.9, CI 2.6-30.2, p<.01, Table 1), whereas the presence of PD signal was not (OR 1.1, CI 0.2-6.1, p=1.0). Corresponding positive predictive values were 71% and 29%, respectively. Patients with synovitis or PD in at least one joint developed arthritis earlier than patients without US abnormalities (synovitis: median time to arthritis 11 versus 14 months, p<0.01; PD: median time to arthritis 5 versus 12 months, p<0.01; Fig 1) with corresponding HRs of 3.5 (CI 1.5-7.9, p<0.01) and 6.9 (CI 1.5-32.2, p<0.02) respectively.

Conclusion:

Synovitis on US predicted arthritis development in seropositive arthralgia patients. This association was not found for PD, however PD frequency was low and therefore the power to predict arthritis was low. However, when taking into account the time to arthritis development, both synovitis and PD were associated with an increased hazard on developing arthritis.


Figure 1. Kaplan-Meier survival curve for (A) synovitis and (B) Power Doppler (PD) and arthritis development

 


Disclosure: A. Blanken, None; M. van Beers-Tas, None; M. Meursinge Reynders, None; D. van Schaardenburg, None.

To cite this abstract in AMA style:

Blanken A, van Beers-Tas M, Meursinge Reynders M, van Schaardenburg D. Ultrasound Abnormalities Predict Arthritis Development in ACPA and/or RF Positive Arthralgia Patients [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/ultrasound-abnormalities-predict-arthritis-development-in-acpa-andor-rf-positive-arthralgia-patients/. Accessed .

ACR Meeting Abstracts - https://acrabstracts.org/abstract/ultrasound-abnormalities-predict-arthritis-development-in-acpa-andor-rf-positive-arthralgia-patients/

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology